OPZELURA™ (ruxolitinib) cream 1.5% PROGRAM TERMS AND CONDITIONS:

1. By opting in to the OPZELURA (ruxolitinib) cream 1.5% Text Message Program (the "Program"), you consent to receive approximately 15 text messages and/or push notifications per month from EngagedMedia LLC ("EngagedMedia") on behalf of Incyte Corporation ("Incyte") using autodialer technology (including text messages). Consent is not a condition of purchase. Such messages may be marketing or non-marketing messages and may include, for example, refill reminders, fill confirmation, website information, etc. Carriers are NOT liable for delayed or undelivered messages.

2. To stop receiving text messages, text STOP to 918-30 or the short code from which you received a message. DOING SO WILL ONLY OPT YOU OUT OF THE OPZELURA (ruxolitinib) cream 1.5% Text Message Program; you will remain opted in to any other Incyte text message program(s) to which you separately opted in. If enrolled in push notifications, you may unsubscribe at any time by going into the digital wallet on your device and disabling push notifications in the digital wallet Program pass or by removing the digital wallet Program pass from your device.

3. To request more information or to obtain help, text HELP to 918-30 or the short code from which you received a message. You can also call customer service at 1-800-583-6964.

4. By opting in to the Program, you also agree to sharing your phone number with EngagedMedia for the purpose of enrolling you into the text program, and with Indegene Inc. ("Indegene"), Incyte's third party partner.

5. You represent that you are the account holder for the mobile telephone number(s) that you provide to opt in to the texting program. You are responsible for notifying Incyte immediately if you change your mobile telephone number. You may notify Incyte of a number change by re-enrolling in the program.

6. Message and data rates may apply to each text message sent or received in connection with the texting program, as provided in your mobile telephone service rate plan, in addition to any applicable roaming charges. Charges are both billed and payable to your mobile service provider or deducted from your prepaid account. Incyte does not impose a separate fee for sending text messages.

7. Data obtained from you in connection with the Program may include your telephone number; your carrier's name; and the date, time, content of your messages, and device information. This data may be used by EngagedMedia to administer the Program, and shared with Indegene. Please read our full Privacy Policy, which is incorporated by reference into these Terms and Conditions.

8. In addition to the data use practices described in the Privacy Policy, Incyte may send you offer-related push notifications when your device is in the physical proximity of your pharmacy or healthcare provider. This is done through geofencing technology, which is built in to your device. Your device's location will not be known or tracked by Incyte or its service providers. Nonetheless, you may opt out of geofencing and receiving these notifications at any time by (1) disabling location services for your digital wallet app in your device's settings, (2) disabling notifications (i.e., automatic updates) within the digital wallet app, or (3) removing the eCard from your digital wallet by selecting "Remove Pass" within the digital wallet app.

9. Neither Incyte nor EngagedMedia will be liable for any delays in the receipt of any SMS messages, as delivery is subject to effective transmission from your network operator.

10. This service is available only on US participating mobile carriers.

11. You agree to indemnify Incyte and EngagedMedia in full for all claims, expenses, and damages related to or caused in whole or in part by your failure to notify us if you change your telephone number, including but not limited to all claims, expenses, and damages related to or arising under the Telephone Consumer Protection Act.

12. NO CLASS ACTIONS: you may only bring individual claims. Under no circumstance are you allowed to bring a claim as a punitive or named plaintiff or a class member in a class. Class action lawsuits, class-wide arbitrations, private attorney-general actions, and any other proceedings where someone acts in a representative capacity are not allowed. Any combining of individual proceedings must have the consent of all parties.

13. Incyte may suspend or terminate your receipt of text messages if it believes you are in breach of these Terms and Conditions. Your receipt of text messages is also subject to termination in the event that your mobile telephone service terminates or lapses. Incyte reserves the right to modify or discontinue, temporarily or permanently, all or any part of the text messaging services you receive, with or without notice.

14. Incyte may revise, modify, or amend these Terms and Conditions at any time. Any such revision, modification, or amendment shall take effect when it is posted to Incyte's website. You agree to review these Terms and Conditions periodically to ensure that you are aware of any changes. Your continued consent to receive text messages will indicate your acceptance of those changes.

Copay Savings Card for OPZELURA Terms and Conditions

By using the copay savings card for OPZELURA, the patient and, if applicable, the healthcare provider and/or pharmacist, acknowledges that the patient meets the eligibility criteria and understands the Terms and Conditions described below:

The patient is not eligible to use this copay savings card if they are enrolled in a state or federally funded prescription insurance program, including, but not limited to, Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as “La Reforma de Salud”)
The patient must have commercial insurance. Offer is not valid for cash-paying patients
By using this copay savings card at participating pharmacies, eligible patients with commercial prescription drug insurance coverage for OPZELURA may pay as little as $0 per tube. Eligible patients whose commercial insurance plan does not cover OPZELURA will pay $35 per prescription and will only be able to redeem this offer at certain participating pharmacies. Other offers may be available for these patients at other pharmacies
Individual out-of-pocket cost may vary based on the price at the pharmacy
Maximum benefits per tube and per calendar year apply. For more information, call 833-613-2333
This copay savings card is not valid when the entire cost of the patient's prescription drug is eligible to be reimbursed by their commercial insurance plan or any other health or pharmacy benefit program
Neither the patient, nor the patient's guardian, pharmacist, or doctor may seek any third-party reimbursement for the value of the copay savings received under this offer
The patient is responsible for reporting use of the copay savings card to any commercial insurer, health plan, or other third party that pays for or reimburses any part of the prescription filled using the copay savings card, as may be required. The patient should not use the copay savings card if their insurer or health plan prohibits use of manufacturer copay cards
This copay savings card is not valid where prohibited by law. The $35 offer is not valid for Massachusetts patients whose commercial insurance does not cover OPZELURA
This copay savings card cannot be combined with any other savings, free trial, or similar offer for the specified prescription
This copay savings card will be accepted only at participating pharmacies
This copay savings card is not health insurance
Offer good only in the U.S. and Puerto Rico
The copay savings card benefit may not be redeemed more than once per 25 days per patient
Offer valid only for an FDA-approved use
No other purchase is necessary
Data related to the patient's redemption of the copay savings card may be collected, analyzed, and shared with Incyte or its affiliates for market research and other purposes related to assessing Incyte’s programs
By enrolling in this copay savings program, the patient acknowledges that Incyte may use their information and share it with providers or their insurance plan in connection with providing copay savings support and for the other purposes related to the copay savings program. Incyte may also share the patient's information with its subsidiaries, affiliates, representatives, agents, and contractors. Incyte may also de-identify the patient's information and use the de-identified information for Incyte’s business purposes

Offer expires December 31, 2024. Incyte reserves the right to rescind, revoke, or amend this offer at any time without notice.

For questions or additional support call 833-613-2333 Monday through Friday, 8 AM - 8 PM ET.

Please see Full Prescribing Information, including Boxed Warning, and Medication Guide for OPZELURA.